Central R&D, AR&D, and the Humnabad manufacturing site

Radison Labs combines Central R&D in Hyderabad with AR&D (analytical research and development) capabilities so chemistry, process understanding, and regulatory-grade data evolve together. Synthetic teams focus on route design, impurity strategy, and robust conditions, while analytical colleagues develop and validate methods, plan stability, and support specifications that stay aligned with pharmacopoeias and customer needs.

The same organisation supports technology transfer into the WHO-GMP manufacturing footprint in Humnabad—so development reports, batch records, and validation packages reflect what is actually run on the plant floor. This integrated model shortens learning cycles when campaigns move from lab to pilot to commercial scale.

Whether you need early route scouting, registration batches, or post-approval changes, the Central R&D and AR&D teams work alongside quality and regulatory colleagues to keep filings coherent—including Korean Drug Master Files (KDMF), EU written confirmation and related documentation, and other global filing pathways referenced in our regulatory roadmap.